Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total value of $1,077,700.00. Following the transaction, the general counsel owned 118,084 shares of the company’s stock, valued at approximately $12,725,912.68. This represents a 7.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Philip Mazzara also recently made the following trade(s):
- On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $117.47, for a total value of $1,174,700.00.
- On Tuesday, February 17th, Philip Mazzara sold 4,849 shares of Astera Labs stock. The shares were sold at an average price of $123.80, for a total value of $600,306.20.
Astera Labs Stock Performance
Shares of ALAB stock opened at $117.14 on Friday. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The firm has a market capitalization of $20.06 billion, a PE ratio of 96.02, a price-to-earnings-growth ratio of 2.31 and a beta of 1.78. The stock has a fifty day moving average of $131.56 and a two-hundred day moving average of $159.09.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on ALAB shares. Barclays set a $165.00 target price on Astera Labs in a report on Thursday, January 15th. Citigroup assumed coverage on Astera Labs in a research report on Thursday. They set a “buy” rating and a $200.00 price target on the stock. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Loop Capital started coverage on Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 target price for the company. Finally, Royal Bank Of Canada began coverage on Astera Labs in a report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $199.44.
Read Our Latest Analysis on Astera Labs
Key Astera Labs News
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Citi initiated/maintained a Buy and set a $200 price target on ALAB, highlighting PCIe and AI-infrastructure opportunity — a sizable analyst endorsement that can lift sentiment and buying interest. Benzinga Coverage
- Positive Sentiment: Research notes (TipRanks summary) underscore Astera Labs’ PCIe switch leadership and positioning in rack-scale AI connectivity, framing multiyear revenue upside tied to data-center AI buildouts. Astera Labs: Leveraging PCIe Switch Leadership…
- Positive Sentiment: Astera appears on roundups of leading growth stocks with notable insider ownership — a signal some investors use to judge management alignment and conviction, which can support valuation multiple expansion if execution continues. April 2026’s Leading Growth Stocks With Insider Ownership
- Neutral Sentiment: Company announced it will report Q1 2026 results after market close on May 5 and hold a conference call — an imminent catalyst that could swing the stock depending on revenue, margins and guidance. Astera Labs Announces Conference Call…
- Negative Sentiment: Recent articles flag a ~36% YTD decline and call out margin pressure and intensifying competition as key near-term risks; these concerns help explain the share-price pullback despite top-line AI/PCIe tailwinds. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD?
- Negative Sentiment: Analyst commentary and newsletter pieces emphasize margin compression risks even as demand grows — if margins miss or competition accelerates, upside expectations tied to AI/PCIe could be delayed. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD? (Zacks)
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Assetmark Inc. increased its holdings in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Reflection Asset Management bought a new stake in shares of Astera Labs during the 4th quarter worth $25,000. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares in the last quarter. Hilltop National Bank grew its holdings in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after acquiring an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC acquired a new stake in shares of Astera Labs during the fourth quarter worth $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
